Veterinary Medicine Ciprofloxacin Hydrochloride (CAS: 528851-31-2)
Name:Ciprofloxacin Hydrochloride
Molecular Formula: C17H18FN3O3. HCl. H2O
Model No.: 86393-32-0
Function: Antibiotic and Antimicrobial Agents, Disinfectant and Preservatives
Molecular Weight: 385.82
Purity: 99%min
Certificate: CP/USP
Specification:25KG/barrel
Form:white or slightly yellow crystalline powder
Function: antibacterial, respiratory disease, E. coli disease widely used for livestock, poultry, can prevent these diseases.
Use: Genitourinary system for sensitive strains caused infections, respiratory tract infections, gastrointestinal infections, typhoid fever, bone and joint infections, skin and soft tissue infections, sepsis and other systemic infections.
Packing: 25kg/drum

Ciprofloxacin (INN) is an antibiotic useful for the treatment of a number of bacterial infections. It is a second-generation fluoroquinolone. Its spectrum of activity includes most strains of bacterial pathogens responsible for respiratory, urinary tract, gastrointestinal, and abdominal infections, including Gram-negative (Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Legionella pneumophila, Moraxella catarrhalis, Proteus mirabilis, and Pseudomonas aeruginosa), and Gram-positive (methicillin-sensitive, but not methicillin-resistant Staphylococcus aureus, Streptococcus pneumoniae, Staphylococcus epidermidis, Enterococcus faecalis, and Streptococcus pyogenes) bacterial pathogens.

Medical uses
Ciprofloxacin is used to treat a wide variety of infections, including infections of bones and joints, endocarditis, gastroenteritis, malignant otitis externa, respiratory tract infections, cellulitis, urinary tract infections, prostatitis, anthrax, and chancroid.

Ciprofloxacin only treats bacterial infections; It does not treat viral infections such as the common cold. Although for certain uses including acute sinusitis, lower respiratory tract infections and uncomplicated gonorrhea, ciprofloxacin is not considered a first-line agent.

Ciprofloxacin occupies an important role in treatment guidelines issued by major medical societies for the treatment of serious infections, especially those likely to be caused by Gram-negative bacteria, including Pseudomonas aeruginosa. For example, ciprofloxacin in combination with metronidazole is one of several first-line antibiotic regimens recommended by the Infectious Disease Society of America for the treatment of community-acquired abdominal infections in adults. It also features prominently in treatment guidelines for acute pyelonephritis, complicated or hospital-acquired urinary tract infection, acute or chronic prostatitis, certain types of endocarditis, certain skin infections, and prosthetic joint infections.